title: Clinical perspectives on atypical antipsychotics for treatment of agitation.
abstract: In the past, the use of atypical antipsychotics in treating acute agitation was limited by a lack of data in behavioral emergencies and by the lack of intramuscular formulations or alternate rapid-acting oral formulations. This article evaluates current data from studies of atypical antipsychotics in agitated patients in both short- and long-term care settings. For patients with underlying psychosis, intramuscular atypical antipsychotics are effective and help ease the transition from intramuscular therapy in the acute care setting to oral dosing in inpatient or community settings. Evidence exists that atypical antipsychotics demonstrate antiagitation effects in schizophrenic patients for as long as 10 weeks and that overall clinical response may be partly mediated by these antiagitation properties. Intramuscular and oral atypical antipsychotics effectively treat acute agitation in both emergency and long-term care settings. For bipolar patients, these agents are valid therapeutic options for acute as well as longer-term alleviation of manic symptoms, including agitation. Safety concerns, however, limit their use in agitated elderly patients with dementia.
authors.affiliation: Department of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA. eric_caine@urmc.rochester.edu
authors.forename: Eric D
authors.initials: ED
authors.lastname: Caine
mesh_terms: D000208:Acute Disease; D000284:Administration, Oral; D000367:Age Factors; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy / Q000523:psychology; D003704:Dementia / Q000188:drug therapy / Q000523:psychology; D004632:Emergency Medical Services; D006801:Humans; D007273:Injections, Intramuscular; D001523:Mental Disorders / Q000188:drug therapy* / Q000523:psychology*; D011595:Psychomotor Agitation / Q000188:drug therapy* / Q000523:psychology; D012559:Schizophrenia / Q000188:drug therapy; D012565:Schizophrenic Psychology; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents